EICHOR
● Recruiting
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours
Condition: Advanced Solid Tumor · Sponsor: Ipsen
About this study
The purpose of this study is to determine the appropriate dosage, safety and effectiveness of a new study drug IPN01195 in adults with advanced solid tumours. The participants in this study will have advanced solid tumours. 'Advanced solid tumours' refers to cancers that can occur in several places, including cancers in organs or tissues that have spread from their original site to nearby tissues or other parts of the body.
This description comes directly from the study's public registry record.
Talk to the study team
Ipsen Clinical Study Enquiries · See email · clinical.trials@ipsen.com
Always discuss trial participation with your own doctor first.
Locations (13)
| START Mid-West | Grand Rapids, Michigan, United States | Recruiting |
| Sarah Cannon Research Institute (SCRI) - Nashville | Nashville, Tennessee, United States | Recruiting |
| Mary Crowley Cancer Research Centers - Medical City Hospital - Dallas | Dallas, Texas, United States | Recruiting |
| START Mountan Region | West Valley City, Utah, United States | Recruiting |
| Virginia Cancer Specialist- Fairfax | Fairfax, Virginia, United States | Recruiting |
| Centre Léon Bérard - Lyon | Lyon, France | Not Yet Recruiting |
| Paris Saint-Louis | Paris, France | Recruiting |
| IGR-Villejuif | Villejuif, France | Recruiting |
| Istituto Nazionale dei Tumori | Milan, Italy | Recruiting |
| Istituto Nazionale Tumori IRCCS - Fondazione Pascale | Naples, Italy | Recruiting |
| Val D'Hebron | Barcelona, Spain | Recruiting |
| Hospital Universitario Quirónsalud Madrid | Madrid, Spain | Recruiting |
+ 1 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06833008